12 May 2020: Articles
Spinal Cord Ischemia Because of Microvascular Thrombosis in a Patient with Necrotizing Pancreatitis. Case Report and Literature Review
Unusual clinical course, Challenging differential diagnosis, Diagnostic / therapeutic accidents, Management of emergency care, Unexpected drug reaction, Rare disease, Clinical situation which can not be reproduced for ethical reasons
Olaf Patryk Dłuski ABCDEF 1*, Aneta Agnieszka Durmaj ABDEF 1, Maciej Kosieradzki CDEG 1, Maurycy Jonas CDE 1, Benedykt Szczepankiewicz B 2, Jarosław Czerwiński B 1, Agata Adamczyk BD 3, Piotr Palczewski ACDEF 4DOI: 10.12659/AJCR.923273
Am J Case Rep 2020; 21:e923273
Abstract
BACKGROUND: Central nervous system ischemia in acute pancreatitis is rare with only a handful of cases reported in the literature. We report a case of spinal cord ischemia due to microvascular thrombosis complicating acute on chronic pancreatitis.
CASE REPORT: A 37-year-old male was transferred to a university hospital intensive care unit with a diagnosis of acute onset chronic pancreatitis, paraplegia, and multi-organ failure. Laboratory studies showed elevated serum amylase activity and leukocytosis. The patient deteriorated quickly and anemia with thrombocytopenia and coagulation abnormalities developed. Computed tomography showed large pancreatic pseudocyst and ischemic lesions in abdominal organs. Symptoms of paraplegia preceded by the bilateral paresis were noted 7 days from the onset of his disease and magnetic resonance imaging showed ischemia involving the central part of the medullary cone resulting from microvascular thrombosis. The patient underwent endoscopic retrograde cholangiopancreatography and repeated surgery with a number of complications but 2 months later was discharged to rehabilitation center due to persistent neurologic deficit.
CONCLUSIONS: Patients with severe pancreatitis and multiorgan failure requiring intensive care should undergo routine neurological examination to identify and treat deficits early.
Keywords: Disseminated Intravascular Coagulation, Spinal Cord Ischemia, Thrombotic Microangiopathies, Thrombocytopenia
Background
Acute pancreatitis is an inflammatory process of the pancreas, which presents with epigastric pain and increased serum amylase [1]. Up to 70% of cases in the USA are triggered by alcohol overuse or common bile duct gallstones [2,3]. Apart from local complications, acute pancreatitis may result in serious systemic complications, such as systemic inflammatory response syndrome, gastrointestinal bleeding, and multi organ failure [4]. While overall mortality in acute pancreatitis approximates 5%, in severe necrotizing cases it may reach 17% to 30% [5]. Most of the fatal cases (up to 80%) result from bacterial infection of necrotic tissue and septic complications [6]. Significant complications may arise from hematologic disturbances related to acute pancreatitis. Disseminated intravascular coagulation (DIC) or thrombotic microangiopathies (TMAs) accompanying pancreatitis may lead to ischemic injury of multiple organs, however, neurologic sequelae are rarely reported [7–11]. We present a case of spinal cord ischemia in a patient with necrotizing pancreatitis complicated with microvascular thrombosis.
Case Report
A 37-year-old male was transferred to our tertiary care intensive care unit (ICU) from a local hospital with a diagnosis of complicated acute on chronic pancreatitis. Three days earlier (day 0), the patient presented to the local hospital emergency department complaining of severe epigastric pain and progressive lower limbs paresis. His medical history included one episode of alcohol-related acute pancreatitis. On admission, the patient’s vital signs were heart rate 70 beats/minute; blood pressure 126/76 mmHg; saturation 99% at FiO2=0.21; and body temperature 38°C. Examination of the abdominal wall revealed bruising around the umbilicus (Cullen’s sign). The abdomen was tender to palpation, with no signs of peritonitis. Neurological examination showed absent deep tendon reflexes and weakened middle and lower cutaneous reflexes with attenuation of all kinds of sensation below the umbilicus and complete loss of sensation below the knees. Apart from increased amylase level (234 U/L) and leukocytosis (12×103/uL), admission laboratory tests were normal. The patient underwent abdominal computed tomography (CT) and magnetic resonance imaging (MRI) of the lumbar spine. CT revealed a giant pancreatic pseudocyst (20×14×18 cm), impaired contrast enhancement of the left kidney and small subcapsular ischemic foci in both kidneys. MRI showed a central hyper-intense signal on T2-weighted images in the thickened medullary cone sparring the thin rim of tissue on the periphery of the medulla. Acute onset chronic pancreatitis was diagnosed and since medullary infarction was suspected, the patient was given a prophylactic dose of low-molecular-weight heparin (LMWH), and empiric antimicrobial therapy (ertapenem and vancomycin). Within a few hours, mild anemia (hemoglobin 11.7 g/dL) and thrombocytopenia (146×103/uL) developed. On day 2, the patient’s general condition deteriorated. He progressed to acute renal failure requiring hemodialysis and acute liver failure. Paresis transformed into a complete paraplegia. Laboratory tests showed anemia (6.5 g/dL), thrombocytopenia (61×103/uL), decreased fibrinogen (135 mg/dL), increased D-dimers (29.1 ug/mL) and international normalized ratio (INR, 2.1) values, and prolonged activated partial thromboplastin time (aPTT, 40.7 seconds). Unenhanced CT showed hyperdense content in the pancreatic cysts consistent with intracystic bleeding. Fresh frozen plasma and packed red blood cells were administered.
On day 3, the patient was transferred to our hospital in critical condition: he was hypotensive with blood pressure maintained with vasopressors, and he was in septic shock. All cultures on admission (blood, urine, tracheal aspirate, throat and rectal swabs) were negative. The decision to perform an emergency laparotomy was made. The surgery included omentectomy and cholecystectomy due to their necrosis and external drainage of pancreatic cyst. Histopathological examination of the gallbladder revealed multifocal, bile stained, demarcated coagulative necrosis of mucosa accompanied by active inflammatory infiltrate. In deep layers of the wall, especially between muscle bundles, small vessels with fresh thrombosis were noticed (Figure 1). A CT on day 7 revealed ischemic foci in the liver and spleen and necrotic tissue in the pancreatic head and body and was followed by relaparotomy with pancreatic necrosectomy and lesser sac and rectovesical pouch drainage (Figure 2). After surgery, a mixed pancreatobiliary fistula was observed with an output of up to 500 mL of amylase-rich (50–90×103 U/L) fluid per day. The next 2 weeks of conservative treatment included total parenteral nutrition, somatostatin, 8 sessions of hemodiafiltration, 4 hemodialysis sessions, and 4 packs of red cell concentrate transfusion, packed platelets, and fresh frozen plasma transfusion. Platelets count normalized on day 9 and hemoglobin level on day 12 and the patient was transferred from the ICU to the surgical ward on day 13. He underwent a follow up MRI on day 21 that showed persistent hyperintense signal on T2-weighted images in the central part of the medullary cone accompanied with patchy contrast enhancement (Figure 3). Due to persistent pancreatic fistula, the patient was scheduled for an endoscopic retrograde cholangiopancreatography (ERCP). Atrial fibrillation and cardiac arrest complicated the first ERCP on day 26, however, at the second attempt on day 40, 2 stents were introduced to the common bile duct and Wirsung duct. On day 57, the patient was discharged from the hospital in good general condition and without fistula symptoms and referred for intensive rehabilitation. A year later, the patient remained severely disabled: he developed lower-limb muscle atrophy and contractures in the talocrural regions, had no deep tendon reflexes and middle and lower cutaneous reflexes and did not have any kind of sensation below the knees. He regained moderate flexion and extension in the hips, which allowed him to change body position and sit without arm support. He also moved from a wheel-chair to a bed and opposite freely. The patient could walk by a wall with orthosis or with therapist help. He developed urinary retention requiring intermittent self-catheterization, suffered from erectile dysfunction, but had no problems with defecation. An MRI at 4.5 months after the incident showed severe atrophy of the medullary cone with central gliosis (Figure 3).
Discussion
Central nervous system ischemia complicating acute pancreatitis is extremely rare with only a handful of cases reported in the literature. Wei et al. were the first to report on spinal cord infarction in a patient with acute pancreatitis, pseudo-cyst formation, and splenic infarction [11]. Soumian et al. presented a case of acute paraplegia in a patient with a ruptured hemorrhagic pancreatic pseudocyst, however, an exact cause of paraplegia was not explained with imaging or during autopsy [7]. Henin et al. described an MRI-confirmed medullary cone infarction during septic shock in a patient with choledocholithiasis-related cholangitis [9]. The patient had a history of a recent episode of acute onset chronic alcoholic pancreatitis with transient acute renal failure. Brain ischemia in the course of acute pancreatitis has also been reported [8,10]. Ludwig et al. reported scattered left cerebral hemisphere cortical infarctions in a patient with necrotizing acute onset chronic pancreatitis, splenic and left renal vein thrombosis. Imaging showed the thrombus in internal carotid artery without underlying atherosclerosis [8]. In our patient ischemia seems to have risen from a small vessel thrombosis. While most cases of spinal cord ischemia are due to anterior spinal artery syndrome, which affects anterior two-thirds of the thoracic cord, in our patient ischemic lesion was within the medullary cone, usually surrounded by arterial circulation arising from both anterior and posterior spinal arteries [12,13]. Sparring of the periphery of the cone suggests that ischemia occurred in the territory of small vessels located further away from the arterial circulation. Findings in other organs confirm this supposition: imaging showed scattered ischemic foci in the kidneys, liver, and spleen and surgical exploration revealed ischemic necrosis of the omentum and gallbladder with microvascular thrombosis seen in histopathology. Other factors might have contributed to the neurologic outcome of our patient. The patient had neurologic symptoms before he deteriorated and became hypotensive, however, considering a well-known susceptibility of lumbar spinal cord to global ischemic events, hypotension might have had a role in aggravating the ischemic insult [14]. The presence of very large (20×14×18 cm) pancreatic pseudo-cyst and inflammatory process in the abdominal cavity most likely increased intra-abdominal pressure, which might have caused congestion in the valveless spinal veins [15].
The constellation of microvascular thrombosis, anemia, thrombocytopenia, and organ failure found in our patient may occur both in disseminated intravascular coagulation (DIC) and thrombotic microangiopathies (TMAs) such as thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) [16]. DIC is much more common than TTP and HUS and changes in laboratory studies showing fibrinogen depletion, increased D-dimers, and prolonged aPTT were typical of DIC, however, they occurred a few days after neurologic symptoms [16,17]. Initially, our patient had mild anemia and thrombocytopenia without coagulopathy, suggestive of TMA [16,18,19]. Acute pancreatitis and TMAs are mutually related: there are reports of TTP/HUS both preceding pancreatitis and occurring in the course of it [20–24]. In our patient, lack of preceding diarrhea and melaena/hematochezia and the presence of neurologic complications make TTP more probable than HUS [16,18,19]. Pancreatitis in TMAs results from a disruption of pancreatic blood supply from microvascular thrombosis [21]. The key pathophysiological mechanism in TTP is a deficiency of ADAMTS13, a metalloproteinase that cleaves ultra large von Willebrand Factor (UL-vWF) multimers [25]. Those multimers bind to, activate, and aggregate platelets, therefore low ADAMTS-13 activity promotes the formation of platelet-rich thrombi in small vessels throughout the body causing organ failure [25]. The kidneys are prone to injury in TTP from low expression of CD36 transmembrane protein [23,25]. Idiopathic TTP is caused by protease-directed autoantibodies [26]. The exact mechanism of TTP development in patients with acute pancreatitis is still not established clearly, however, apart from antibodies, multiple factors that may disturb ADAMTS13/vWF balance in the setting of systemic inflammation either by inhibition of ADAMTS-13 or increased vWF production have been identified (e.g., interleukins, cytokines, coagulation factors, enzymes) [20,22,25,27–29]. Low ADAMTS-13 activity has been also observed in DIC [30,31]. Patients with sepsis-induced DIC who have a severely reduced ADAMTS13 activity have a clinical profile indistinguishable from that of patients with primary TMA [30]. Low ADAMTS13 activity is associated with risk of renal failure and worse outcome in patients with DIC or sepsis irrespective of DIC [30]. The reports on coexistence of DIC and TMA are not uncommon [25,32]. Based on the clinical course and laboratory test results, we believe that it was also the case in our patient and that overlapping of DIC and TTP leading to microvascular thrombotic occlusion in different mechanisms was responsible for bulky systemic thrombosis. The treatment in our patient was therefore aimed to both remove the cause of DIC (antibiotic therapy, pancreatic cyst drainage, necrosectomy) and limit the effects of TTP (hemodiafiltration, fresh frozen plasma administration, hemodialysis) [33].
Several diagnostic algorithms for DIC and TMA have been published [34–36]. Recently, Vincent et al. proposed a practical approach for interventionists to distinguish DIC from TMA [16]. In patients with thrombocytopenia, microangiopathic hemolytic anemia and organ dysfunction diagnostics should start with coagulation profile (prothrombin time, aPTT, D-dimers). If findings in coagulation profile are not specific for DIC, the next steps should include assessment of ADAMTS13 activity and stool culture/PCR for Shiga-toxin-producing
Due to very few cases reported in the literature, there is no proven treatment that could prevent or limit the progression of the spinal cord ischemia associated with TMAs.
Conclusions
Coagulation abnormalities in the form of TMA and/or DIC may aggravate the course of pancreatitis. Considering serious consequences of this complication, a high index of suspicion is recommended, and blood morphology and coagulation profile should be observed with caution in patients with pancreatitis.
References:
1.. Vege SS, Pathogenesis of acute pancreatitis In: http://www.uptodate.com
2.. Forsmark CE, Baillie J, [AGA Institute technical review on acute pancreatitis]: Rev Gastroenterol Mex, 2007; 72; 257-85, pmid: 18402218
3.. Yang AL, Vadhavkar S, Singh G, Omary MB, Epidemiology of alcohol-related liver and pancreatic disease in the United States: Arch Intern Med, 2008; 168; 649-56, pmid: 18362258
4.. Banks PA, Bollen TL, Dervenis C, Classification of acute pancreatitis – 2012: Revision of the Atlanta classification and definitions by international consensus: Gut, 2013; 62; 102-11, pmid: 23100216
5.. Banks PA, Freeman ML, Practice guidelines in acute pancreatitis: Am J Gastroenterol, 2006; 101; 2379-400, pmid: 17032204
6.. Maher MM, Lucey BC, Gervais DA, Mueller PR, Acute pancreatitis: The role of imaging and interventional radiology: Cardiovasc Intervent Radiol, 2004; 27; 208-25, pmid: 15024494
7.. Soumian S, Manimaran N, Jones B, Ruptured pseudocyst of pancreas presenting with paraplegia: A case report: Cases J, 2009; 2; 9336, pmid: 20062595
8.. Ludwig DR, Austin MJ, Wallace AN, Isolated internal carotid artery thrombus and cerebral infarction in a patient with necrotizing pancreatitis: Case report: J Stroke Cerebrovasc Dis, 2018; 27; e1-e4, pmid: 28893576
9.. Henin P, Molderez A, Huberlant V, Trine H, Spinal cord infarction in the course of a septic shock: About one case and review of the literature: Case Rep Crit Care, 2017; 2017; 1571048, pmid: 28316845
10.. Vinod KV, Verma SP, Karthikeyan B, Cerebral infarction leading to hemiplegia: A rare complication of acute pancreatitis: Indian J Crit Care Med, 2013; 17; 308-10, pmid: 24339644
11.. Wei SC, Kao JH, Lee WY, Acute pancreatitis complicated by infarction of the spleen and spinal cord: J Formos Med Assoc, 1997; 96; 754-57, pmid: 9308332
12.. Lazorthes G, Gouaze A, Zadeh JO, Arterial vascularization of the spinal cord: J Neurosurg, 1971; 35; 253-62, pmid: 22046635
13.. Anderson NE, Willoughby EW, Infarction of the conus medullaris: Ann Neurol, 1987; 21; 470-74, pmid: 3592640
14.. Duggal N, Lach B, Selective vulnerability of the lumbosacral spinal cord after cardiac arrest and hypotension: Stroke, 2002; 33; 116-21, pmid: 11779899
15.. Willey JZ, Barnett HJM, Mohr JP, Spinal cord ischemia: Stroke pathophysiology, diagnosis, and management, 2011; 643-60, Elsevier Saunders
16.. Vincent J-L, Castro P, Hunt BJ, Thrombocytopenia in the ICU: Disseminated intravascular coagulation and thrombotic microangiopathies – what intensivists need to know: Crit Care, 2018; 22; 158, pmid: 29895296
17.. Boral BM, Williams DJ, Boral LI, Disseminated intravascular coagulation: Am J Clin Pathol, 2016; 146; 670-80, pmid: 28013226
18.. Jokiranta TS, Sakari Jokiranta T, HUS and atypical HUS: Blood, 2017; 129; 2847-56, pmid: 28416508
19.. Joly BS, Coppo P, Veyradier A, Thrombotic thrombocytopenic purpura: Blood, 2017; 129; 2836-46, pmid: 28416507
20.. Daryanani S, Wilde JT, Relapsing thrombotic thrombocytopenic purpura in association with recurrent pancreatitis: Clin Lab Haematol, 1998; 20; 317-18, pmid: 9807681
21.. McDonald V, Laffan M, Benjamin S, Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: A report of seven cases from a regional UK TTP registry: Br J Haematol, 2009; 144; 430-33, pmid: 19036107
22.. Silva VA, Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome secondary to pancreatitis: Am J Hematol, 1995; 50; 53-56, pmid: 7668225
23.. Boyer A, Chadda K, Salah A, Bonmarchand G, Thrombotic microangiopathy: An atypical cause of acute renal failure in patients with acute pancreatitis: Intensive Care Med, 2004; 30; 1235-39, pmid: 15069598
24.. Fu P, Yuan A-H, Wang C-H, Alcohol-induced severe acute pancreatitis followed by hemolytic uremic syndrome managed with continuous renal replacement therapy: BMC Nephrol, 2014; 15; 1, pmid: 24386889
25.. Schwameis M, Schörgenhofer C, Assinger A, VWF excess and ADAMTS13 deficiency: A unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP: Thromb Haemost, 2015; 113; 708-18, pmid: 25503977
26.. Tsai H-M, Lian EC-Y, Antibodies to von Willebrand factor – cleaving protease in acute thrombotic thrombocytopenic purpura: N Engl J Med, 1998; 339; 1585-94, pmid: 9828246
27.. Mannucci PM, Capoferri C, Canciani MT, Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease: Br J Haematol, 2004; 126; 213-18, pmid: 15238142
28.. Claus RA, Bockmeyer CL, Sossdorf M, Lösche W, The balance between von-Willebrand factor and its cleaving protease ADAMTS13: Biomarker in systemic inflammation and development of organ failure?: Curr Mol Med, 2010; 10; 236-48, pmid: 20196724
29.. Bockmeyer CL, Claus RA, Budde U, Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor: Haematologica, 2008; 93; 137-40, pmid: 18166799
30.. Ono T, Mimuro J, Madoiwa S, Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure: Blood, 2006; 107; 528-34, pmid: 16189276
31.. Habe K, Wada H, Ito-Habe N, Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases: Thromb Res, 2012; 129; 598-602, pmid: 22070827
32.. Sakamaki Y, Konishi K, Hayashi K, Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation: BMC Nephrol, 2013; 14; 260, pmid: 24279773
33.. George JN, How I treat patients with thrombotic thrombocytopenic purpura: 2010: Blood, 2010; 116; 4060-69, pmid: 20686117
34.. Scully M, Hunt BJ, Benjamin S, Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies: Br J Haematol, 2012; 158; 323-35, pmid: 22624596
35.. Wada H, Thachil J, Di Nisio M, Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines: J Thromb Haemost, 2013 [Epub ahead of print]
36.. Azoulay E, Knoebl P, Garnacho-Montero J, Expert statements on the standard of care in critically ill adult patients with atypical hemolytic uremic syndrome: Chest, 2017; 152; 424-34, pmid: 28442312
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






